AI-CVD vs FibriCheck
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your primary objective is to perform opportunistic screening for cardiovascular and multisystem diseases by leveraging existing CT scans. This platform is ideal for identifying hidden health risks such as coronary artery calcium or aortic calcification without requiring additional imaging, radiation, or workflow disruption, providing automated, quantitative measurements from previously acquired data.
View AI-CVD →Choose FibriCheck if…
Choose FibriCheck if you require a convenient, patient-centric solution for remote heart rhythm monitoring and arrhythmia detection. This smartphone-based application empowers patients to regularly check their heart rhythm, providing immediate, AI-powered analysis for conditions like Atrial Fibrillation, and is well-suited for ongoing management and early detection of irregular heartbeats outside of clinical settings with clinician oversight.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-CVD | FibriCheck |
|---|---|---|
| Pricing | Unknown | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Unknown | Cloud-based (private cloud). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FibriCheckFibriCheck is a patient-facing mobile application designed for intuitive use with just a smartphone, making heart rhythm monitoring highly accessible for end-users. AI-CVD integrates into existing clinical workflows for healthcare providers, which is efficient but less directly focused on broad patient usability. FibriCheck's direct patient-centric design for a consumer device gives it an edge in general usability.
Clinical Value
AI-CVDAI-CVD performs opportunistic screening for a broad range of cardiovascular and multisystem diseases using existing CT scans, providing early detection of hidden health risks through multiple quantitative measurements. While FibriCheck offers valuable arrhythmia detection, AI-CVD's ability to leverage existing data for comprehensive, early detection across multiple disease markers offers a broader scope of clinical value.
Pricing & Value
FibriCheckFibriCheck provides transparent and detailed pricing for both end-users and healthcare providers, including subscription tiers and per-measurement options. AI-CVD requires contacting the vendor for pricing, making it difficult to assess its value proposition without further inquiry. FibriCheck's clear pricing structure offers greater transparency and ease of evaluation.
Enterprise Readiness
FibriCheckFibriCheck is medically certified, explicitly HIPAA compliant, cloud-based, and offers licensing agreements for healthcare providers and clinical centers, indicating clear readiness for enterprise adoption, particularly for remote patient monitoring. AI-CVD is FDA-cleared and cloud-deployed, but its BAA and HIPAA compliance are stated as 'likely, contact vendor,' suggesting less explicit public information.
Innovation
AI-CVDAI-CVD innovates by extracting a wealth of new, clinically relevant information for opportunistic screening across multiple disease states from *existing* CT scans, without requiring additional imaging or workflow disruption. FibriCheck innovatively uses a smartphone camera for medically certified heart rhythm monitoring, democratizing access to cardiac care. However, AI-CVD's ability to repurpose high-cost imaging data for broad, early disease detection represents a potentially larger paradigm shift in diagnostic efficiency.
Support & Docs
FibriCheckFibriCheck explicitly offers an 'optional medical expert review for anomalous measurements,' indicating a direct support mechanism for patients regarding their results. AI-CVD's provided information does not detail any specific support or documentation offerings. Therefore, FibriCheck demonstrates a clearer, albeit limited, offering in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | FibriCheck |
|---|---|---|
| Product Name | AI-CVD | FibriCheck |
| Company | HeartLung Corporation | Qompium nv |
| Primary Function/Description | AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. | Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone. |
| Technology & Data Source | AI-powered quantitative imaging platform; uses existing chest and abdominal CT scans. | Smartphone camera-based PPG technology; AI-powered algorithm for arrhythmia detection and analysis. |
| Key Cardiac Measurements/Detections | Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing. | Detection of Atrial Fibrillation (AFib) and other arrhythmias. |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and FibriCheck.